Status:
SUSPENDED
Efficacy of Ovarian Stimulation Based on FSHR Genotype Status
Lead Sponsor:
Medical University of Vienna
Conditions:
Sterility
Eligibility:
FEMALE
18-40 years
Phase:
PHASE3
Brief Summary
Available data from in vitro studies and clinical trials indicate that genetic factors play a significant role in the success of controlled ovarian stimulation (COS) prior to in vitro fertilization - ...
Detailed Description
Women in group A will undergo controlled ovarian stimulation according to the following protocol: Pituitary down-regulation will be achieved using buserelin (Suprefact®, Hoechst, Frankfurt, Germany) ...
Eligibility Criteria
Inclusion
- Age between 18 and 40
- Informed consent
- Indication for IVF-ET
Exclusion
- Inability to understand written informed consent form
- Personal history of ovarian hyperstimulation syndrome
Key Trial Info
Start Date :
May 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2015
Estimated Enrollment :
165 Patients enrolled
Trial Details
Trial ID
NCT00749853
Start Date
May 1 2015
End Date
June 1 2015
Last Update
May 5 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Vienna
Vienna, Vienna, Austria, A-1090